RecruitingNCT05609474

Trajectories and Reactions of Users and Relatives Consulting French Youth Addiction Services

Trajectories and Reactions of Users and Relatives Consulting French Youth Addiction Services (Consultations Jeunes Consommateurs)


Sponsor

Hôpital le Vinatier

Enrollment

1,430 participants

Start Date

Feb 15, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

In France, the "Consultations Jeunes Consommateurs" (CJC) are the services specialized in the reception of young people for addiction problems. There are more than 500 CJCs throughout France. Depending on the situation, the CJC develops an early intervention strategy aimed either at reducing the risk of developing an addiction or at accelerating entry into appropriate care. The CJCs also meet with family members or professionals who may also independently request help or advice. Set up by the State since 2004, the action of the CJCs has never been formally evaluated. Only descriptive studies, carried out by the French Observatory of Drugs and Drug Addiction (OFDT), have made it possible to better understand the profile of people who consult CJCs. However, no longitudinal study has yet been carried out to understand the factors associated with the overall evolution of users consulting CJCs, nor with the level of satisfaction of users and those around them. Such objectives are complex, due to the diversity of situations encountered in CJCs and the heterogeneity of the CJCs themselves.


Eligibility

Min Age: 12 YearsMax Age: 25 Years

Inclusion Criteria6

  • For users :
  • First consultation in CJC
  • From 12 to 25 years old
  • For caregivers :
  • First consultation in CJC (with or without the youth) or second consultation if accompanying a user
  • ≥ 18 ans

Exclusion Criteria2

  • inability to reach by phone
  • Insufficient french level

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Centre Hospitalier Le Vinatier

Bron, Auvergne-Rhône-Alpes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05609474


Related Trials